Jacks Lee
Fortune : 398 539 $ au 30/06/2026
Fortune : 398 539 $ au 30/06/2026
Jacks Lee worked as Senior Vice President-Manufacturing & Supply at Merck & Co., Inc. from 2007 to 2023.
Served as Independent Director at G1 Therapeutics, Inc. from 2022 to 2024.
Served as Independent Director at Vaxcyte, Inc. from 2023 to 2026.
Education includes graduate degree from the University of Central Missouri and undergraduate degree from the University of Wisconsin.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 6 856 ( 0 % ) | 398 539 $ | 30/06/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| VAXCYTE, INC. | Directeur/Membre du Conseil | 17/06/2026 |
| G1 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 18/09/2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/06/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
University of Central Missouri
University of Central Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national